Company number 10726172
Status Active
Incorporation Date 13 April 2017
Company Type Private Limited Company
Address UNIT 6 EDISON VILLAGE, NOTTINGHAM SCIENCE PARK, NOTTINGHAM, UNITED KINGDOM, NG7 2RF
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc
Since the company registration nine events have happened. The last three records are Appointment of Ms Stephanie Anne Hamblin as a director on 24 May 2017; Statement of capital following an allotment of shares on 19 May 2017
GBP 10.53
; Statement of capital following an allotment of shares on 2 May 2017
GBP 1
. The most likely internet sites of MARLIN THERAPEUTICS LTD are www.marlintherapeutics.co.uk, and www.marlin-therapeutics.co.uk. The predicted number of employees is 1 to 10. The company’s age is eight years and ten months. Marlin Therapeutics Ltd is a Private Limited Company.
The company registration number is 10726172. Marlin Therapeutics Ltd has been working since 13 April 2017.
The present status of the company is Active. The registered address of Marlin Therapeutics Ltd is Unit 6 Edison Village Nottingham Science Park Nottingham United Kingdom Ng7 2rf. . BATES, Timothy Edward, Dr is a Director of the company. DAINTY, Roger James is a Director of the company. HAMBLIN, Stephanie Anne is a Director of the company. The company operates in "Research and experimental development on biotechnology".
Current Directors
Persons With Significant Control
Dr Timothy Edward Bates
Notified on: 13 April 2017
65 years old
Nature of control: Ownership of shares – 75% or more
MARLIN THERAPEUTICS LTD Events
24 May 2017
Appointment of Ms Stephanie Anne Hamblin as a director on 24 May 2017
24 May 2017
Statement of capital following an allotment of shares on 19 May 2017
18 May 2017
Statement of capital following an allotment of shares on 2 May 2017
18 May 2017
Statement of capital following an allotment of shares on 2 May 2017
16 May 2017
Sub-division of shares on 2 May 2017
12 May 2017
Appointment of Roger James Dainty as a director on 10 May 2017
09 May 2017
Current accounting period shortened from 30 April 2018 to 31 March 2018
13 Apr 2017
Incorporation
Statement of capital on 2017-04-13
-
MODEL ARTICLES ‐
Model articles adopted